Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

吡罗昔康贴片 - NMPA Drug Approval Details

Approvals/NMPA/Piroxicam Patch

Approved

化学药品

Piroxicam Patch

SK CHEMICALS CO., LTD.🇨🇳 National Medical Products Administration

Approval Date: Aug 19, 2021
Approval ID: 8CYmkdpAPN5
Company: SK CHEMICALS CO., LTD.
Type: 化学药品

Approval Details

Approval Id: 8CYmkdpAPN5
Approval Number: 国药准字HJ20160607
Generic Name: 吡罗昔康贴片
Generic Name En: Piroxicam Patch
Drug Type: 化学药品
Dosage Form: 贴剂
Strength: 48.0mg
Reg Date: 2021-08-19
Expired Date: 2026-08-18
Company Name: SK CHEMICALS CO., LTD.
Production Company Name: SK CHEMICALS CO., LTD.
Company Detail Path: /organization/sk-chemicals-co-ltd
Production Company Detail Path: /organization/sk-chemicals-co-ltd

Approved

Quick Info

Agency

NMPA

Country

🇨🇳

Approval Date

Aug 19, 2021

Approval ID

8CYmkdpAPN5

Type

化学药品

Back to NMPA Approvals